Dextrose
NDC Package 51662-1306-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dextrose is injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1306 and is authorized under FDA application NDA016367.

Identification & Billing

NDC Package Code
51662-1306-1
Package Description
1 BAG in 1 POUCH / 100 mL in 1 BAG
Product Code
11-Digit Billing Format
51662130601
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dextrose
Dosage Form
-
Usage Information
Dextrose Injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
FDA Application #
NDA016367
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-06-2018
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1306-1 identifies a specific commercial package of 1 bag in 1 pouch / 100 ml in 1 bag of Dextrose, labeled by Hf Acquisition Co Llc, Dba Healthfirst. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on October 06, 2018. The current certification is valid through December 31, 2024.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662130601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1306-1
11-Digit CMS (5-4-2)
51662-1306-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.